Altium Capital Management LP Iovance Biotherapeutics, Inc. Transaction History
Altium Capital Management LP
- $283 Million
- Q3 2024
A detailed history of Altium Capital Management LP transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Altium Capital Management LP holds 300,000 shares of IOVA stock, worth $1.82 Million. This represents 1.58% of its overall portfolio holdings.
Number of Shares
300,000Holding current value
$1.82 Million% of portfolio
1.58%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding IOVA
# of Institutions
320Shares Held
239MCall Options Held
3.77MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA27.3MShares$166 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY26.6MShares$162 Million6.53% of portfolio
-
Mhr Fund Management LLC New York, NY24MShares$146 Million28.52% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$129 Million0.0% of portfolio
-
State Street Corp Boston, MA13.2MShares$80.1 Million0.01% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $958M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...